Midterm Safety and Performance of a Leadless Cardiac Pacemaker: 3-Year Follow-up to the LEADLESS Trial (Nanostim Safety and Performance Trial for a Leadless Cardiac Pacemaker System). [electronic resource]
- Circulation 02 2018
- 633-635 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't
1524-4539
10.1161/CIRCULATIONAHA.117.030106 doi
Aged Aged, 80 and over Arrhythmias, Cardiac--diagnosis Cardiac Pacing, Artificial--adverse effects Clinical Trials as Topic Equipment Design Female Humans Male Pacemaker, Artificial--adverse effects Retrospective Studies Risk Assessment Risk Factors Time Factors Treatment Outcome